🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Austria / NCT07028983
Recruiting Not applicable

Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music

NCT07028983 · tracked via the Priya Life Science Austria tracker
Phase
Not applicable
Started
2025-07-01
Last updated
2026-09-10

Condition(s) studied

Substance Use Disorder (SUD)

Investigational drug(s) / intervention(s)

Active Music Group (AMG)Music Listening Group (MLG)Treatment as Usual (TAU)

Active Music Group (AMG): Active music group is a music therapy intervention where participants actively make/play music in groups. The sessions will be conducted by an appropriately qualified music therapist.

Music Listening Group (MLG): Music listening group is a music therapy intervention where participants partake in music listening in groups. The sessions will be conducted by an appropriately qualified music therapist.

Treatment as Usual (TAU): Treatment as usual as provided locally, which may include pharmacological and/or non-pharmacological interventions (e.g. mindfulness-based intervention, structured physical activity).

Study summary

FALCO is a parallel pragmatic randomized control trial addressing long-term effects of music therapy (MT) on substance use disorder (SUD).

600 participants will be recruited from multiple European countries (see Locations). They will be randomized into one of the following intervention arms: Active Music Group (AMG), Music Listening Group (MLG) or Treatment as Usual (TAU) as offered locally.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients seeking or receiving treatment at the recruitment site for an existing substance use disorder based on ICD-10 criteria * ≥18 years old * not currently undergoing detoxification (detoxification has been completed or is not currently planned at the time of recruitment) * any type of substance use including polysubstance and alcohol use Exclusion Criteria: * exclusively nicotine dependence * psychotic episode in the last 3 months * insufficient language skills to participate in treatment without the use of a translator * hearing impairment that considerably impairs hearing of music played at a moderate volume (not relevant if hearing is sufficiently compensated by a hearing aid) * existing diagnosis of dementia * is currently receiving music therapy or has received music therapy (i.e. at planned and reoccurring intervals, not counting single random occurrences) during the past year

Primary outcome measure(s)

Trial sites (11)

FacilityCityRegionStatus
Anton Proksch Institut Vienna Austria Recruiting
Herzog College Jerusalem Israel Recruiting
University of Pavia Pavia Italy Recruiting
University of Bergen / NORCE Research AS Bergen Norway Recruiting
Sykehuset Innlandet Innlandet Norway Suspended
Stavanger Universitetssjukehus Stavanger Norway Suspended
Palestinian National Rehabilitation Centre Bethlehem Palestinian Territories Not Yet Recruiting
WOTU / University of Gdansk Gdansk Poland Recruiting
Fundacio Sanitaria d'Igualada Barcelona Spain Recruiting
IDIBGI Girona Spain Withdrawn
CAD Zurich Switzerland Recruiting

More NORCE Norwegian Research Centre AS trials in Austria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07028983 on ClinicalTrials.gov ↗ ← All trials in Austria